XML 18 R11.htm IDEA: XBRL DOCUMENT v3.25.0.1
Business Operations
6 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business Operations

Note 3. – Business Operations

 

The Company’s continuing operations are composed of a pharmacy business. A subsidiary, SunLink Health Systems Technology (“SHST Technology”), an information technology (“IT”) business that was sold in January 2025. Its net assets and liabilities are shown as current assets held for sale and current liabilities held for sale on the December 31, 2024 condensed consolidated balance sheet.

The pharmacy business, is composed of four operational areas conducted in three locations in southwest Louisiana:

 

· Retail pharmacy products and services, consisting of retail pharmacy sales.

 

· Institutional pharmacy services consisting of the provision of specialty and non-specialty pharmaceutical and biological products to institutional clients or to patients in institutional settings, such as extended care and rehabilitation centers, nursing homes, assisted living facilities, behavioral and specialty hospitals, hospice, and correctional facilities.

 

· Non-institutional pharmacy services consisting of the provision of specialty and non-specialty pharmaceutical and biological products to clients or patients in non-institutional settings including private residential homes.

 

· Durable medical equipment products and services (“DME”), consisting primarily of the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care.


COVID-19 Pandemic

 

The Company’s operations for the six months ended December 31, 2024 continued to be negatively impacted by the effects of the aftermath of the COVID-19 pandemic, although mitigated somewhat from prior quarters, including among other factors, difficulty hiring qualified employees, rising labor and supply costs, and supply chain challenges resulting in inability to obtain pharmacy and DME products on a timely, cost effective basis.